Characterization and evaluation of a new oncolytic Vaccinia Virus strain LIVP6.1.1 for canine cancer therapy

Virotherapy on the basis of oncolytic vaccinia virus (VACV) strains is one novel approach for canine cancer therapy. In this study we described for the first time the characterization and the use of new VACV strain LIVP6.1.1 as an oncolytic agent against canine cancer in a panel of four canine cance...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Gentschev, Ivaylo, Patil, Sandeep S., Adelfinger, Marion, Weibel, Stephanie, Geissinger, Ulrike, Frentzen, Alexa, Chen, Nanhai G., Yu, Yong A., Zhang, Qian, Ogilvie, Gregory, Szalay, Aladar A.
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2013
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3609626/
https://ncbi.nlm.nih.gov/pubmed/23093804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/bioe.22462
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki